QUICK SEARCH:   [advanced]
Author:
Keyword(s):
Year:  Vol:  Page: 

   

 

Health Affairs, 24, no. 1 (2005): 195-205
doi: 10.1377/hlthaff.24.1.195
© 2005 by Project HOPE
 
New Online
 * McAllen, TX & Beyond: An Expert Roundtable
 * Geography & Reform
 * Medicaid or Insurance Exchange?
 * Siren Song of New GME
 * Public Plan Option: Pro & Con
This Article
* Full Text (HTML)
* Reprint (PDF)
* Submit a response to this article
* Alert me when this article is cited
* Alert me when Comments are posted
* Alert me if a correction is posted
Services
* E-mail this article to a friend
* Similar articles in this journal
* Similar articles in ISI Web of Science
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Personal Archive
* Download to Citation Manager
*Reprints & Permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via ISI Web of Science (31)
* Citing Articles via Google Scholar
Google Scholar
* Articles by Zuvekas, S. H.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Zuvekas, S. H.
Related Collections
* Access To Care
* Health Reform
* Insurance Coverage
* Insurance - Employer-Based System
* Business Of Health
* Mental Health/Substance Abuse
* Pharmaceuticals
* Health Spending
* Consumer Issues
* Insurance Market

Health Tracking

TRENDS

Prescription Drugs And The Changing Patterns Of Treatment For Mental Disorders, 1996–2001

Samuel H. Zuvekas

This paper uses detailed data on prescription drug and other services from the Medical Expenditure Panel Survey (MEPS) to examine recent trends in mental health and substance abuse (MH/SA) treatment between 1996 and 2001. While use of ambulatory services remained constant, prescription drug use increased rapidly, with the result that 5.5 million more Americans received treatment in 2001. Prescription drug spending increased at a real rate of almost 20 percent a year. About one-third of this increase came from more MH/SA medication users and two-thirds from higher costs per user.


Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati    What's this?


This article has been cited by other articles:


Home page
Health Aff (Millwood)Home page
S. H. Zuvekas and C. D. Meyerhoefer
State Variations In The Out-Of-Pocket Spending Burden For Outpatient Mental Health Treatment
Health Aff., May 1, 2009; 28(3): 713 - 722.
[Abstract] [Full Text] [PDF]


Home page
Health Aff (Millwood)Home page
K. R. Levit, C. A. Kassed, R. M. Coffey, T. L. Mark, E. M. Stranges, J. A. Buck, and R. Vandivort-Warren
Future Funding For Mental Health And Substance Abuse: Increasing Burdens For The Public Sector
Health Aff., November 1, 2008; 27(6): w513 - w522.
[Abstract] [Full Text] [PDF]


Home page
Psychiatr. Serv.Home page
H. M. Gonzalez, T. Croghan, B. West, D. Williams, R. Nesse, W. Tarraf, R. Taylor, L. Hinton, H. Neighbors, and J. Jackson
Antidepressant Use in Black and White Populations in the United States
Psychiatr Serv, October 1, 2008; 59(10): 1131 - 1138.
[Abstract] [Full Text] [PDF]


Home page
Psychiatr. Serv.Home page
J. M. Donohue and R. G. Frank
Estimating Medicare Part D's Impact on Medication Access Among Dually Eligible Beneficiaries With Mental Disorders
Psychiatr Serv, October 1, 2007; 58(10): 1285 - 1291.
[Abstract] [Full Text] [PDF]


Home page
Psychiatr. Serv.Home page
T. L. Mark, K. R. Levit, J. A. Buck, R. M. Coffey, and R. Vandivort-Warren
Mental Health Treatment Expenditure Trends, 1986 2003
Psychiatr Serv, August 1, 2007; 58(8): 1041 - 1048.
[Abstract] [Full Text] [PDF]


Home page
Health Aff (Millwood)Home page
J. M. Polinski, P. S. Wang, and M. A. Fischer
Medicaid's Prior Authorization Program And Access To Atypical Antipsychotic Medications
Health Aff., May 1, 2007; 26(3): 750 - 760.
[Abstract] [Full Text] [PDF]


Home page
Health Aff (Millwood)Home page
B. G. Druss
Rising mental health costs: what are we getting for our money?
Health Aff., May 1, 2006; 25(3): 614 - 622.
[Abstract] [Full Text] [PDF]


Home page
Health Aff (Millwood)Home page
H. A. Huskamp
Prices, profits, and innovation: examining criticisms of new psychotropic drugs' value.
Health Aff., May 1, 2006; 25(3): 635 - 646.
[Abstract] [Full Text] [PDF]


Home page
Health Aff (Millwood)Home page
J. Donohue
Mental health in the medicare part d drug benefit: a new regulatory model?
Health Aff., May 1, 2006; 25(3): 707 - 719.
[Abstract] [Full Text] [PDF]


Home page
Health Aff (Millwood)Home page
N. E. Morden and L. P. Garrison Jr.
Implications of part d for mentally ill dual eligibles: a challenge for medicare.
Health Aff., March 1, 2006; 25(2): 491 - 500.
[Abstract] [Full Text] [PDF]


Home page
Health Aff (Millwood)Home page
S. H. Zuvekas, A. E. Rupp, and G. S. Norquist
The Impacts Of Mental Health Parity And Managed Care In One Large Employer Group: A Reexamination
Health Aff., November 1, 2005; 24(6): 1668 - 1671.
[Abstract] [Full Text] [PDF]


Home page
Policy Politics Nursing PracticeHome page
P. Rosenfeld, H. Kim, G. Londono, C. Kovner, and M. Mezey
Adult Ambulatory Care Visits to Nurses and Physicians: Methodological Limitations of the Medical Expenditure Panel Survey Data
Policy Politics Nursing Practice, August 1, 2005; 6(3): 221 - 228.
[Abstract] [PDF]



Home | Current Issue | Archives | Topic Collections | Search | Blog | Subscribe | Contact Us | Help

© 2001-2005 Project HOPE–The People-to-People Organization
Terms and Policies